216 related articles for article (PubMed ID: 23644669)
1. Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
Hervier B; Devilliers H; Benveniste O
Ann Rheum Dis; 2013 Jul; 72(7):e18. PubMed ID: 23644669
[No Abstract] [Full Text] [Related]
2. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis.
Targoff IN
J Immunol; 1990 Mar; 144(5):1737-43. PubMed ID: 2307838
[TBL] [Abstract][Full Text] [Related]
3. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis.
Goldstein R; Duvic M; Targoff IN; Reichlin M; McMenemy AM; Reveille JD; Warner NB; Pollack MS; Arnett FC
Arthritis Rheum; 1990 Aug; 33(8):1240-8. PubMed ID: 1975177
[TBL] [Abstract][Full Text] [Related]
4. Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies.
Miller FW; Twitty SA; Biswas T; Plotz PH
J Clin Invest; 1990 Feb; 85(2):468-75. PubMed ID: 1688885
[TBL] [Abstract][Full Text] [Related]
5. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.
Targoff IN; Trieu EP; Miller FW
J Clin Invest; 1993 Jun; 91(6):2556-64. PubMed ID: 8514867
[TBL] [Abstract][Full Text] [Related]
6. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
[TBL] [Abstract][Full Text] [Related]
8. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity.
Targoff IN; Reichlin M
J Immunol; 1987 May; 138(9):2874-82. PubMed ID: 3553328
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of the cloned human autoantigen, histidyl-tRNA synthetase. Analysis of the myositis-associated anti-Jo-1 autoimmune response.
Ramsden DA; Chen J; Miller FW; Misener V; Bernstein RM; Siminovitch KA; Tsui FW
J Immunol; 1989 Oct; 143(7):2267-72. PubMed ID: 2476503
[TBL] [Abstract][Full Text] [Related]
10. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity.
Mathews MB; Bernstein RM
Nature; 1983 Jul 14-20; 304(5922):177-9. PubMed ID: 6866113
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive insight into human aminoacyl-tRNA synthetases as autoantigens in idiopathic inflammatory myopathies.
Jura M; Rychlewski L; Barciszewski J
Crit Rev Immunol; 2007; 27(6):559-72. PubMed ID: 18197801
[TBL] [Abstract][Full Text] [Related]
12. Intranuclear location of the myositis-specific Jo-1 antigen: hopping histidyl-tRNA synthetase?
Dang CV
Arthritis Rheum; 1985 Jul; 28(7):839-40. PubMed ID: 2409986
[No Abstract] [Full Text] [Related]
13. [Anti-Jo-1 antibody and anti-aminoacyl-tRNA synthetase antibody as a marker autoantibody for myositis].
Kinoshita M
Nihon Rinsho; 1990 Feb; 48 Suppl():482-4. PubMed ID: 2355568
[No Abstract] [Full Text] [Related]
14. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
[TBL] [Abstract][Full Text] [Related]
15. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.
Yamasaki Y; Yamada H; Nozaki T; Akaogi J; Nichols C; Lyons R; Loy AC; Chan EK; Reeves WH; Satoh M
Arthritis Rheum; 2006 Jun; 54(6):2004-9. PubMed ID: 16732549
[TBL] [Abstract][Full Text] [Related]
16. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease.
Hirakata M; Suwa A; Nagai S; Kron MA; Trieu EP; Mimori T; Akizuki M; Targoff IN
J Immunol; 1999 Feb; 162(4):2315-20. PubMed ID: 9973509
[TBL] [Abstract][Full Text] [Related]
17. Human anti-asparaginyl-tRNA synthetase autoantibodies (anti-KS) increase the affinity of the enzyme for its tRNA substrate.
Beaulande M; Kron M; Hirakata M; Härtlein M
FEBS Lett; 2001 Apr; 494(3):170-4. PubMed ID: 11311235
[TBL] [Abstract][Full Text] [Related]
18. The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome.
Schneider F; Aggarwal R; Bi D; Gibson K; Oddis C; Yousem SA
Arch Pathol Lab Med; 2015 Jan; 139(1):122-5. PubMed ID: 25549148
[TBL] [Abstract][Full Text] [Related]
19. Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody.
Yang DC; Dang CV; Arnett FC
Biochem Biophys Res Commun; 1984 Apr; 120(1):15-21. PubMed ID: 6712685
[TBL] [Abstract][Full Text] [Related]
20. Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase.
Walker EJ; Tymms KE; Webb J; Jeffrey PD
J Immunol Methods; 1987 Feb; 96(2):149-56. PubMed ID: 3100649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
